Antitumor efficacy of 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone in lung cancer xenografts. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I.

Please provide your email address to receive an email when new articles are posted on . The addition of pemetrexed plus platinum chemotherapy to the immune checkpoint inhibitor pembrolizumab showed ...

The FDA has approved a generic form of the intravenous chemotherapy pemetrexed for use by itself in patients with locally advanced or metastatic non-squamous non-small cell lung cancer that has not ...

Surgery alone or in a multi-modality approach in the management of patients (pts) with Malignant Pleurant Mesothelioma (MPM): A 15-years experience This is an ASCO Meeting Abstract from the 2004 ASCO ...

Please provide your email address to receive an email when new articles are posted on . “Sintilimab [Tyvyt; Eli Lilly & Co., Innovent Biologics] is a fully human IgG4 monoclonal antibody that blocks ...

"The claim that pemetrexed is superior in adenocarcinoma is one that is not supported by the US FDA [US Food and Drug Administration] and is not supported by a careful consideration of the evidence," ...

Introduction: Malignant pleural mesothelioma (MPM) is a rapidly progressive tumor that is increasing in frequency worldwide. Treatment options are limited, and response to chemotherapy is poor. The ...

The median OS was not reached at the time of the data cut-off in the pembrolizumab plus chemotherapy arm and was 11.3 months for those in the chemotherapy arm. The Food and Drug Administration (FDA) ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the Phase III IMpower132 study of TECENTRIQ ® ...

Transcription factors involved in EMT such as Snail, Slug, TWIST and the ZEB families mainly repress expression of E-cadherin during EMT. 30, 31, 32, 33 The ...

Gastric cancer is one of the leading causes of cancer-related death worldwide. There were debates on the value of the second-line and beyond chemotherapy by the time we designed this trial. So we ...

The first trial of an important new combination therapy of treatment with the chemotherapy drug pemetrexed concurrent with radiation in lung cancer has delivered promising results. The first trial of ...